Biobank for pulmonary hypertension and related conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to establish a biobank that collects biological samples such as blood, urine, and stool from patients diagnosed with pulmonary hypertension, systemic sclerosis, mixed connective tissue disease, and healthy controls. The goal is to gather specimens that will be stored for future research into the pathobiology of pulmonary hypertension and the development of biomarkers to improve clinical care. Participants will be recruited from the Comprehensive Pulmonary Hypertension Center and those undergoing right heart catheterization.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR
* Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR
* Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR
* Undergoing outpatient right heart catheterization

Exclusion Criteria:

* Age\<18
* Pregnant
* Unable to understand English
* Currently incarcerated
* Unwilling or unable to sign informed consent

Where it's running

• University Medical Center-New Orleans
  New Orleans, Louisiana, United States Recruiting

Study contacts

• Study coordinator: Matthew R Lammi, MD, MSCR
• Email: mlammi@lsuhsc.edu
• Phone: 5045684634

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry and biorepository for rheumatic diseases

  This study is collecting samples and health information from adults with rheumatic diseases at Yale clinics to help researchers learn more about these conditions and improve future treatments.

  Recruiting Yale University · New Haven, Connecticut · NCT04402086

• High-dose immunoablative therapy with stem cell transplantation for systemic sclerosis

  This study is testing a high-dose treatment followed by stem cell transplantation to see if it can help people with systemic sclerosis feel better and stay healthier.

  Recruiting at 3 sites Phase 2 University of Pittsburgh · Pittsburgh, Pennsylvania and 2 other locations · NCT03630211

• Levosimendan to see if it helps the heart after PEA in CTEPH

  This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk · NCT07914933

• Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD

  This study tests whether inhaled treprostinil added to standard care can improve exercise-related lung blood flow and function in adults with ILD or CTD who develop pulmonary hypertension during exercise.

  Recruiting at 2 sites Early Phase 1 Valley Health System · Paramus, New Jersey and 1 other locations · NCT07837830

• Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension

  This study tests a Brazilian Portuguese version of the EmPHasis-10 questionnaire to see if it reliably measures quality of life in adults with pulmonary hypertension in Porto Alegre, Brazil.

  Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre · NCT07822997

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.